TY - JOUR T1 - Angiogenesis in epithelian ovarian cancer JF - Molecular Pathology JO - Mol Pathol SP - 348 LP - 359 DO - 10.1136/mp.55.6.348 VL - 55 IS - 6 AU - E S Bamberger AU - C W Perrett Y1 - 2002/12/01 UR - http://mp.bmj.com/content/55/6/348.abstract N2 - Angiogenesis, the development of new blood vessels from the existing vasculature, is an essential component of solid tumour growth and metastasis. Several angiogenic factors are expressed by many tumours, suggesting that tumours promote their own vascularisation by activating the host endothelium. This review will discuss various angiogenic stimulators and inhibitors in epithelian ovarian cancer (EOC), including vascular endothelial growth factor and platelet derived endothelial cell growth factor/thymidine phosphorylase. The analysis of tumour vascularisation by microvessel density will also be discussed and the relevance of these markers of angiogenesis in the prognosis of EOC will be assessed. ER -